In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferation.

Abstract:

:Expression of B7 family costimulatory molecules on B cells defines their capacity to function as antigen presenting cells (APCs). B cells that do not express B7 costimulatory molecules induce T-cell tolerance. Therefore, the expression of B7 costimulatory molecules on malignant B cells might be critical for their recognition by anti-tumor-specific T cells. Here we show that virtually all germinal center (GC)-derived B-cell lymphomas including follicular lymphoma (FL) and diffuse large cell lymphoma, but not mantle cell lymphoma or small lymphocytic lymphomas (SLL/CLL), express B7-1 (CD80) and B7-2 (CD86) on their cell surface in situ, although at extremely low levels. Despite their expression of low levels of B7-1 and B7-2, FL cells could not induce significant allogeneic T-cell proliferation. However, B7 costimulatory molecules on FL appeared to be functional because they were capable of increasing T-cell proliferation of preactivated T cells in a secondary allogeneic mixed lymphocyte response. Moreover, low B7 expression was sufficient to prevent the induction of alloantigen-specific anergy in vitro. Therefore, we postulate that whereas low-level expression of B7 is not sufficient to initiate a productive antilymphoma T-cell response, it might be sufficient to prevent T-cell tolerance in vivo.

journal_name

Blood

journal_title

Blood

authors

Dorfman DM,Schultze JL,Shahsafaei A,Michalak S,Gribben JG,Freeman GJ,Pinkus GS,Nadler LM

subject

Has Abstract

pub_date

1997-12-01 00:00:00

pages

4297-306

issue

11

eissn

0006-4971

issn

1528-0020

journal_volume

90

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Crystal structure and functional interpretation of the erythrocyte spectrin tetramerization domain complex.

    abstract::As the principal component of the membrane skeleton, spectrin confers integrity and flexibility to red cell membranes. Although this network involves many interactions, the most common hemolytic anemia mutations that disrupt erythrocyte morphology affect the spectrin tetramerization domains. Although much is known cli...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-01-261396

    authors: Ipsaro JJ,Harper SL,Messick TE,Marmorstein R,Mondragón A,Speicher DW

    更新日期:2010-06-10 00:00:00

  • An evolutionarily ancient mechanism for regulation of hemoglobin expression in vertebrate red cells.

    abstract::The oxygen transport function of hemoglobin (HB) is thought to have arisen ∼500 million years ago, roughly coinciding with the divergence between jawless (Agnatha) and jawed (Gnathostomata) vertebrates. Intriguingly, extant HBs of jawless and jawed vertebrates were shown to have evolved twice, and independently, from ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020004826

    authors: Miyata M,Gillemans N,Hockman D,Demmers JAA,Cheng JF,Hou J,Salminen M,Fisher CA,Taylor S,Gibbons RJ,Ganis JJ,Zon LI,Grosveld F,Mulugeta E,Sauka-Spengler T,Higgs DR,Philipsen S

    更新日期:2020-07-16 00:00:00

  • Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma.

    abstract::In Burkitt lymphoma/leukemia (BL), achievement of complete remission with first-line chemotherapy remains a challenging issue, as most patients who respond remain disease-free, whereas those refractory have few options of being rescued with salvage therapies. The mechanisms underlying BL chemoresistance and how it can...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-02-268003

    authors: Richter-Larrea JA,Robles EF,Fresquet V,Beltran E,Rullan AJ,Agirre X,Calasanz MJ,Panizo C,Richter JA,Hernandez JM,Roman-Gomez J,Prosper F,Martinez-Climent JA

    更新日期:2010-10-07 00:00:00

  • IgH partner breakpoint sequences provide evidence that AID initiates t(11;14) and t(8;14) chromosomal breaks in mantle cell and Burkitt lymphomas.

    abstract::Previous studies have implicated activation-induced cytidine deaminase (AID) in B-cell translocations but have failed to identify any association between their chromosomal breakpoints and known AID target sequences. Analysis of 56 unclustered IgH-CCND1 translocations in mantle cell lymphoma across the ~ 344-kb bcl-1 b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-02-412791

    authors: Greisman HA,Lu Z,Tsai AG,Greiner TC,Yi HS,Lieber MR

    更新日期:2012-10-04 00:00:00

  • Endothelial cell protein C receptor cellular localization and trafficking: potential functional implications.

    abstract::Although the binding of endothelial cell protein C receptor (EPCR) to its ligands is well characterized at the biochemical level, it remains unclear how EPCR interaction with its ligands at the cell surface impacts its cellular trafficking. We characterized the cellular localization and trafficking of EPCR in endothel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-208900

    authors: Nayak RC,Sen P,Ghosh S,Gopalakrishnan R,Esmon CT,Pendurthi UR,Rao LV

    更新日期:2009-08-27 00:00:00

  • Hepatosplenic T-cell lymphoma: a rare but challenging entity.

    abstract::Hepatosplenic T-cell lymphoma (HSTCL) is a rare T-cell neoplasm that most commonly arises from a small subset of γ/δ T-cell receptor-expressing lymphocytes. HSTCL is more common in adolescent and young adults and has a rapidly progressive clinical course and poor outcome due to its refractoriness to conventional chemo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004118

    authors: Pro B,Allen P,Behdad A

    更新日期:2020-10-29 00:00:00

  • Growth and development following marrow transplantation for leukemia.

    abstract::One hundred forty-two patients between the ages of 1 and 17 years who survived disease-free more than 1 year after marrow transplantation for hematologic malignancy had growth and development evaluations from one to 14 years posttransplant (median 4 years). Prior to transplant all children received multiagent chemothe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sanders JE,Pritchard S,Mahoney P,Amos D,Buckner CD,Witherspoon RP,Deeg HJ,Doney KC,Sullivan KM,Appelbaum FR

    更新日期:1986-11-01 00:00:00

  • In vitro generation of HSC-like cells from murine ESCs/iPSCs by enforced expression of LIM-homeobox transcription factor Lhx2.

    abstract::Identification of genes involved in in vitro differentiation induction of embryonic stem cells (ESCs) into hematopoietic stem cells (HSCs) has been challenged during last decade. To date, a homeobox transcription factor Hoxb4 has been only demonstrated to possess such an effect in mice. Here, we show that HSC-like cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-07-298596

    authors: Kitajima K,Minehata K,Sakimura K,Nakano T,Hara T

    更新日期:2011-04-07 00:00:00

  • VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.

    abstract::In human follicular lymphoma the t(14; 18) chromosome translocation activates the antiapoptotic oncogene Bcl2 by linking it to the immunoglobulin heavy chain (IGH) locus. Transgenic mice expressing Bcl2 controlled by an Igh enhancer (E mu) do not develop follicular lymphoma, although they do have an increased incidenc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2469

    authors: Egle A,Harris AW,Bath ML,O'Reilly L,Cory S

    更新日期:2004-03-15 00:00:00

  • Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.

    abstract::An acquired gain-of-function mutation in the Janus kinase 2 (JAK2-V617F) is frequently found in patients with myeloproliferative disorders (MPDs). To test the hypothesis that JAK2-V617F is the disease-initiating mutation, we examined whether all cells of clonal origin carry the JAK2-V617F mutation. Using allele-specif...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2005-11-009605

    authors: Kralovics R,Teo SS,Li S,Theocharides A,Buser AS,Tichelli A,Skoda RC

    更新日期:2006-08-15 00:00:00

  • Perforin is a critical physiologic regulator of T-cell activation.

    abstract::Individuals with impaired perforin-dependent cytotoxic function (Ctx(-)) develop a fatal inflammatory disorder called hemophagocytic lymphohistiocytosis (HLH). It has been hypothesized that immune hyperactivation during HLH is caused by heightened infection, defective apoptosis/responsiveness of Ctx(-) lymphocytes, or...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-324533

    authors: Lykens JE,Terrell CE,Zoller EE,Risma K,Jordan MB

    更新日期:2011-07-21 00:00:00

  • Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing.

    abstract::Many researchers have speculated that the clinical progression from monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma (MM) is driven by defects in dendritic cell (DC) function. However, evidence supporting this assumption is controversial, and no mechanism for the putative DC dysfunction ha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-01-623975

    authors: Leone P,Berardi S,Frassanito MA,Ria R,De Re V,Cicco S,Battaglia S,Ditonno P,Dammacco F,Vacca A,Racanelli V

    更新日期:2015-09-17 00:00:00

  • Notch signaling in acute lymphoblastic leukemia: any role for stromal microenvironment?

    abstract::Notch signaling pathway regulates many different events of embryonic and adult development; among them, Notch plays an essential role in the onset of hematopoietic stem cells and influences multiple maturation steps of developing lymphoid and myeloid cells. Deregulation of Notch signaling determines several human diso...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2011-08-376061

    authors: Nwabo Kamdje AH,Krampera M

    更新日期:2011-12-15 00:00:00

  • Approach to the treatment of multiple myeloma: a clash of philosophies.

    abstract::In this Perspective, we summarize some of the most contentious issues surrounding diagnosis and treatment of myeloma. We outline how a fundamental clash of philosophies, cure versus control, may be at the heart of many of the controversies. From the very definition of the disease to risk stratification to the validity...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-297853

    authors: Rajkumar SV,Gahrton G,Bergsagel PL

    更新日期:2011-09-22 00:00:00

  • A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion.

    abstract::Human alpha2-antiplasmin (alpha2AP), also known as alpha2-plasmin inhibitor, is the major inhibitor of the proteolytic enzyme plasmin that digests fibrin. There are 2 N-terminal forms of alpha2AP that circulate in human plasma: a 464-residue protein with Met as the N-terminus, Met-alpha2AP, and a 452-residue version w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-12-4240

    authors: Lee KN,Jackson KW,Christiansen VJ,Chung KH,McKee PA

    更新日期:2004-05-15 00:00:00

  • The supernatant of apoptotic cells causes transcriptional activation of hypoxia-inducible factor-1alpha in macrophages via sphingosine-1-phosphate and transforming growth factor-beta.

    abstract::Macrophages infiltrating solid tumors exhibit a tumor-supporting phenotype and are critical for tumor development. Little is known which tumor-derived signal provokes this phenotype shift and how these signals are interpreted in macrophages to support tumor growth. We used the supernatant of apoptotic cells and notice...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-01-201889

    authors: Herr B,Zhou J,Werno C,Menrad H,Namgaladze D,Weigert A,Dehne N,Brüne B

    更新日期:2009-09-03 00:00:00

  • Detection of cytarabine resistance in patients with acute myelogenous leukemia using flow cytometry.

    abstract::Cytarabine (Ara-C) is currently used in the treatment of adult acute myeloid leukemia (AML). To predict the results of induction chemotherapy, it could be useful to detect leukemic cells that are resistant to Ara-C in patients with AML. Using a bromodeoxyuridine/DNA (BrdUrd/DNA) staining method in flow cytometry (FCM)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lacombe F,Belloc F,Dumain P,Puntous M,Makhoul PC,Saux MC,Bernard P,Boisseau MR,Reiffers J

    更新日期:1994-08-01 00:00:00

  • The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents.

    abstract::The SRC family kinases (SFKs) and the receptor tyrosine kinase c-Kit are activated in human acute myeloid leukemia (AML) cells. We show here that the SFKs LYN, HCK, or FGR are overexpressed and activated in AML progenitor cells. Treatment with the SFK and c-KIT inhibitor dasatinib selectively inhibits human AML stem/p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-11-466425

    authors: Dos Santos C,McDonald T,Ho YW,Liu H,Lin A,Forman SJ,Kuo YH,Bhatia R

    更新日期:2013-09-12 00:00:00

  • Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia.

    abstract::Pure red cell aplasia (PRCA) is a rare complication in patients with chronic lymphocytic leukemia (CLL). It is characterized by reticulocytopenia and by an absence of red cell precursors in the bone marrow. Unlike autoimmune hemolytic anemia, which is characterized by an increased number of reticulocytes, positive Coo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.3.1092

    authors: Ghazal H

    更新日期:2002-02-01 00:00:00

  • Mcl-1L cleavage is involved in TRAIL-R1- and TRAIL-R2-mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells.

    abstract::We evaluated the ability of 2 human mAbs directed against TRAILR1 (HGS-ETR1) and TRAILR2 (HGS-ETR2) to kill human myeloma cells. HGS-ETR1 and HGS-ETR2 mAbs killed 15 and 9 human myeloma cell lines (HMCLs; n = 22), respectively. IL-6, the major survival and growth factor for these HMCLs, did not prevent their killing. ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-12-007971

    authors: Menoret E,Gomez-Bougie P,Geffroy-Luseau A,Daniels S,Moreau P,Le Gouill S,Harousseau JL,Bataille R,Amiot M,Pellat-Deceunynck C

    更新日期:2006-08-15 00:00:00

  • A ricin A chain-containing immunotoxin that kills human T lymphocytes in vitro.

    abstract::An immunotoxin specific for human T lymphocytes was prepared by coupling an IgG2a anti-CD3 murine monoclonal antibody (64.1) to purified ricin A chain (64.1-A). Treatment of blood mononuclear cells with this immunotoxin at a concentration of 1.7 X 10(-9) mol/L for two hours at 37 degrees C in the presence of 20 mmol/L...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Martin PJ,Hansen JA,Vitetta ES

    更新日期:1985-10-01 00:00:00

  • Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412.

    abstract::MCL-1 is a Bcl-2 family member that has been described as antiapoptotic in various myeloid neoplasms. Therefore, MCL-1 has been suggested as a potential new therapeutic target. Systemic mastocytosis (SM) is a myeloid neoplasm involving mast cells (MCs) and their progenitors. In the present study, we examined the expre...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-07-032714

    authors: Aichberger KJ,Mayerhofer M,Gleixner KV,Krauth MT,Gruze A,Pickl WF,Wacheck V,Selzer E,Müllauer L,Agis H,Sillaber C,Valent P

    更新日期:2007-04-01 00:00:00

  • Heterogeneity of breakpoints of 11q23 rearrangements in hematologic malignancies identified with fluorescence in situ hybridization.

    abstract::Twenty-four patients whose cells contained a variety of 11q23 rearrangements, including translocations, insertions, and an inversion, were studied using fluorescence in situ hybridization with cosmid, phage, and plasmid probes mapped to 11q22-24. In 17 patients, the breakpoints of the common 11q23 translocations invol...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kobayashi H,Espinosa R 3rd,Thirman MJ,Gill HJ,Fernald AA,Diaz MO,Le Beau MM,Rowley JD

    更新日期:1993-07-15 00:00:00

  • The early activation of memory B cells from Wiskott-Aldrich syndrome patients is suppressed by CD19 downregulation.

    abstract::Wiskott-Aldrich syndrome (WAS) pediatric patients exhibit a deficiency in humoral immune memory. However, the mechanism by which Wiskott-Aldrich syndrome protein (WASP) regulates the differentiation and activation of memory B cells remains elusive. Here we examine the early activation events of memory B cells from the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-03-703579

    authors: Bai X,Zhang Y,Huang L,Wang J,Li W,Niu L,Jiang H,Dai R,Zhou L,Zhang Z,Miller H,Song W,Zhao X,Liu C

    更新日期:2016-09-29 00:00:00

  • The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice.

    abstract::The transcription factor c-Maf is extensively involved in the pathophysiology of multiple myeloma (MM), a fatal malignancy of plasma cells. In the present study, affinity chromatography and mass spectrometry were used to identify c-Maf ubiquitination-associated proteins, from which the E3 ligase HERC4 was found to int...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-07-658203

    authors: Zhang Z,Tong J,Tang X,Juan J,Cao B,Hurren R,Chen G,Taylor P,Xu X,Shi CX,Du J,Hou J,Wang G,Wu D,Stewart AK,Schimmer AD,Moran MF,Mao X

    更新日期:2016-03-31 00:00:00

  • Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now.

    abstract::Although sickle cell disease (SCD) has a variable clinical course, many patients develop end-organ complications that are associated with significant morbidity and early mortality. Myeloablative allogeneic HSCT (allo-HSCT) is curative but has been historically performed only in children younger than 16 years of age. M...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2011-01-332510

    authors: Hsieh MM,Fitzhugh CD,Tisdale JF

    更新日期:2011-08-04 00:00:00

  • Regulatory control of the terminal complement proteins at the surface of human endothelial cells: neutralization of a C5b-9 inhibitor by antibody to CD59.

    abstract::Functionally inhibitory antibody to the plasma membrane complement inhibitor CD59 has been used to investigate control of the terminal complement proteins at the endothelial cell surface. Antibodies against purified human erythrocyte CD59 (polyclonal anti-CD59 and monoclonal antibodies [MoAbs] 1F1 and 1F5) were found ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hamilton KK,Ji Z,Rollins S,Stewart BH,Sims PJ

    更新日期:1990-12-15 00:00:00

  • The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients.

    abstract::Staining with CD14 and CD16 monoclonal antibodies will identify two monocyte subpopulations in human blood: a major population of regular monocytes, which strongly expresses the CD14 antigen (CD14++), and a minor population with weak expression of CD14 and expression of the CD16 antigen (CD14+/CD16+ cells). As shown h...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fingerle G,Pforte A,Passlick B,Blumenstein M,Ströbel M,Ziegler-Heitbrock HW

    更新日期:1993-11-15 00:00:00

  • Quinine-dependent, platelet-reactive monoclonals mimic antibodies found in patients with quinine-induced immune thrombocytopenia.

    abstract::Drug-induced immune thrombocytopenia (DITP) is caused by drug-dependent antibodies (DDAbs) that are nonreactive in themselves but bind tightly to specific platelet membrane glycoproteins (GP) when soluble drug is present at pharmacologic concentrations. This reaction takes place without covalent linkage of drug to the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-09-177279

    authors: Bougie DW,Birenbaum J,Rasmussen M,Poncz M,Aster RH

    更新日期:2009-01-29 00:00:00

  • Interleukin-3 treatment of rhesus monkeys leads to increased production of histamine-releasing cells that express interleukin-3 receptors at high levels.

    abstract::To understand the hematopoietic and nonhematopoietic responses to interleukin-3 (IL-3), expression of cell-surface IL-3 receptors (IL-3R) was examined on bone marrow (BM) cells and peripheral blood (PB) cells of rhesus monkeys during the course of in vivo IL-3 treatment. Whereas IL-3R expression is low in untreated mo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: van Gils FC,van Teeffelen ME,Neelis KJ,Hendrikx J,Burger H,van Leen RW,Knol E,Wagemaker G,Wognum AW

    更新日期:1995-07-15 00:00:00